2024年11月18日 · The Frontiers in Cancer Science (FCS) 2024 conference took place from November 13-15, 2024, at The Matrix, Biopolis, Singapore. We trust that all delegates had an exceptional time exchanging ideas...

NUS’ Cancer Science Institute (CSI) conducts cutting-edge research to understanding and combating cancer. The comprehensive facilities in the institute support a wide range of research activities, from molecular biology and genomics to clinical applications and drug discovery.

PhD thesis advisor has to be a CSI faculty. Please click here for the list of CSI PIs. Please refer to this document here for the terms and conditions of the CSI Singapore PhD Graduate Scholarship.

The CSI Singapore Graduate Programme seeks to attract top scientific and medical talents interested in a career in cancer research. Graduate students will have access to world-class facilities dedicated to cancer research and can look forward to working with a dynamic team of globally renowned specialised scientists and clinicians in an ...

The Cancer Science Institute of Singapore (CSI Singapore) was officially launched on 15 October 2008. CSI Singapore aims to position Singapore as a global-leader in the field of Biomedical Sciences. It is dedicated to conducting a multifaceted and coordinated approach to cancer research, extending from basic cancer studies all the way to ...

新加坡国际研究生奖（singa）是科学，技术与研究机构（a * star），南洋理工大学（ntu），新加坡国立大学（nus）和新加坡科技设计大学（sutd）之间的合作。 适用于希望在nus攻读科学和工程博士学位的世界各地优秀研究生。仅限：理学院，工程学院，计算机学院。

陈蕾蕾 博士于2012年加入新加坡国立大学癌症研究所(CSI)担任高级研究科学家，并于 2014年6月成为一名独立首席研究员。陈蕾蕾博士同时担任新加坡国立大学Yong Loo Lin医学院解剖学系的副教授的职位。

CSI Singapore aims to train the next generation of cancer researchers to excel both in the scientific and translational aspects of cancer research and contribute original ideas that advance their specific field of cancer research.

2022年8月22日 · The Cancer Science Institute of Singapore (CSI Singapore) aims to position Singapore as a global-leader in the field of Biomedical Sciences. It is dedicated to conducting a multifaceted and coordinated approach to cancer research, extending from basic cancer studies to experimental therapeutics and in so doing improve cancer treatment.

Translational research in oncology, focusing on immunotherapy. RNA alterations in cancer and development of RNA-based therapeutics. Our lab studies ways to overcome high-risk cancers. How cellular pathways maintain genomic integrity in response to intrinsic topological stress. Development of novel treatments for cancers.